Drug resistant Mycobacterium bovis cystitis following intravesical bacillus Calmette-Guerin treatment.
Eichel
L
L
Department of Urology, University of Rochester School of Medicine, New York, USA.
Erturk
E
E
Disant'Agnese
A
A
D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000009:adverse effects*; D000283:Administration, Intravesical; D000368:Aged; D001500:BCG Vaccine / Q000008:administration & dosage / Q000009:adverse effects*; D003556:Cystitis / Q000188:drug therapy* / Q000382:microbiology*; D004352:Drug Resistance, Microbial; D006801:Humans; D008297:Male; D009163:Mycobacterium bovis; D014401:Tuberculosis, Urogenital / Q000188:drug therapy*
D000276:Adjuvants, Immunologic; D001500:BCG Vaccine